Robert Clark
Director/Board Member at INCANNEX HEALTHCARE INC.
Net worth: 230 000 $ as of 29/04/2024
Profile
Robert Bruce Clark currently works at Incannex Healthcare, Inc., as Independent Non-Executive Director from 2022 and Novo Nordisk, Inc., as Vice President-Regulatory Affairs from 2012.
Mr. Clark also formerly worked at Pfizer Inc., as Head-United States Regulatory Strategy from 1992 to 2021.
Mr. Clark received his graduate degree from New York Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INCANNEX HEALTHCARE INC.
0.63% | 20/12/2023 | 100,000 ( 0.63% ) | 230 000 $ | 29/04/2024 |
Robert Clark active positions
| Companies | Position | Start |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Director/Board Member | 16/08/2022 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | General Counsel | 31/12/2011 |
Former positions of Robert Clark
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 31/12/2020 |
Training of Robert Clark
| New York Medical College | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| INCANNEX HEALTHCARE INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Stock Market
- Insiders
- Robert Clark
